Novartis, GlaxoSmithKline and Eli Lilly have hammered out a pact to swap, sell and partner on a group of four different divisions, realigning the corporate and marketing landscape for each of the big three pharma players.

…read more

Source: GlaxoSmithKline punts its cancer R&D work in Big Pharma swap and shop


0 No comments